| Title： | Classification and Stratification of the Eighteen Anti and Nineteen Fear Theories and their Consensus among Pharmaceutical Experts for Clinical Safety Risk Assessment |
| Edition： | Others |
| Classification： | Traditional Chinese Medicine guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Physicians and pharmacists in medical institutions, pharmacists in social pharmacies |
| Evidence classification method： | Improved Delphi Evidence Grading Method |
| Development unit： | Consensus Expert Group |
| Registration time: | 2023-11-26 |
| Registration number： | PREPARE-2023CN958 |
| Purpose of the guideline: | The theory of eighteen contraindications and nineteen contraindications for compatibility is one of the basic theories of traditional Chinese medicine. There has been controversy in the academic and clinical circles for a long time, with some views suggesting that it must be followed as a taboo, while others believe that it should not be used as a taboo and should be used according to the situation. This guideline takes a pharmaceutical perspective and integrates various available data and evidence (basic experiments, clinical experience, ancient literature, etc.) to reach a consensus on the hierarchical classification of the combination of eighteen antibodies and nineteen fears, as well as the methods used for clinical safety risk assessment. |
Latest registration
